Adiposs SA is a clinical-stage life science company a first-in-class disruptive imaging product for cancer patients.
Adiposs has raised $5.0M in total funding. The most recent round was Series A. The last funding was announced in June 2025.
Adiposs's investors include Kickfund, Venture Kick, MassChallenge, Privilège Ventures, FONGIT Innovation Fund.
Adiposs is headquartered in Geneva, Switzerland.
Adiposs SA is a clinical-stage life science company a first-in-class disruptive imaging product for cancer patients.
Adiposs is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Adiposs — Funding & Investors." VCBacked, June 30, 2025, https://www.vcbacked.co/company/adiposs. Accessed July 20, 2026.
VCBacked. (2025). Adiposs — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/adiposs
{{cite web |title=Adiposs — Funding & Investors |url=https://www.vcbacked.co/company/adiposs |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated